Serious adverse drug reactions in children and adolescents treated on- and off-label with antidepressants and antipsychotics in clinical practice
Introduction - Despite the growing evidence base for psychotropic drug - treatment in pediatric patients, knowledge about the benefit-risk ratio in - clinical practice remains limited. The ‘Therapeutic Drug Monitoring - (TDM)-VIGIL’ study aimed to evaluate serious adverse drug reactions - (ADRs) in...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1 September 2022
|
| In: |
Pharmacopsychiatry
Year: 2022, Jahrgang: 55, Heft: 5, Pages: 255-265 |
| ISSN: | 1439-0795 |
| DOI: | 10.1055/a-1716-1856 |
| Online-Zugang: | Resolving-System, kostenfrei: https://doi.org/10.1055/a-1716-1856 Verlag, kostenfrei, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458344/ 
|
| Verfasserangaben: | authors: Karin M. Egberts, Manfred Gerlach, Christoph U. Correll, Paul L. Plener, Uwe Malzahn, Peter Heuschmann, Stefan Unterecker, Maike Scherf-Clavel, Hans Rock, Gisela Antony, Wolfgang Briegel, Christian Fleischhaker, Alexander Häge, Tobias Hellenschmidt, Harmut Imgart, Michael Kaess, Andreas Karwautz, Michael Kölch, Karl Reitzle, Tobias Renner, Su-Yin Reuter-Dang, Christian Rexroth, Gerd Schulte-Körne, Frank M. Theisen, Susanne Walitza, Christoph Wewetzer, Stefanie Fekete, Regina Taurines, Marcel Romanos |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1826462554 | ||
| 003 | DE-627 | ||
| 005 | 20250110020545.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221207s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1055/a-1716-1856 |2 doi | |
| 035 | |a (DE-627)1826462554 | ||
| 035 | |a (DE-599)KXP1826462554 | ||
| 035 | |a (OCoLC)1425217275 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 11 |2 sdnb | ||
| 100 | 1 | |a Egberts, Karin M. |e VerfasserIn |0 (DE-588)1303833786 |0 (DE-627)1860204929 |4 aut | |
| 245 | 1 | 0 | |a Serious adverse drug reactions in children and adolescents treated on- and off-label with antidepressants and antipsychotics in clinical practice |c authors: Karin M. Egberts, Manfred Gerlach, Christoph U. Correll, Paul L. Plener, Uwe Malzahn, Peter Heuschmann, Stefan Unterecker, Maike Scherf-Clavel, Hans Rock, Gisela Antony, Wolfgang Briegel, Christian Fleischhaker, Alexander Häge, Tobias Hellenschmidt, Harmut Imgart, Michael Kaess, Andreas Karwautz, Michael Kölch, Karl Reitzle, Tobias Renner, Su-Yin Reuter-Dang, Christian Rexroth, Gerd Schulte-Körne, Frank M. Theisen, Susanne Walitza, Christoph Wewetzer, Stefanie Fekete, Regina Taurines, Marcel Romanos |
| 264 | 1 | |c 1 September 2022 | |
| 300 | |b Illustrationen, Tabellen, Diagramme | ||
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Introduction - Despite the growing evidence base for psychotropic drug - treatment in pediatric patients, knowledge about the benefit-risk ratio in - clinical practice remains limited. The ‘Therapeutic Drug Monitoring - (TDM)-VIGIL’ study aimed to evaluate serious adverse drug reactions - (ADRs) in children and adolescents treated with antidepressants and/or - antipsychotics in approved (‘on-label’), and off-label use in - clinical practice. - , Methods - Psychiatric pediatric patients aged 6-18 years treated with - antidepressants and/or antipsychotics either on-label or off-label were - prospectively followed between October 2014 and December 2018 within a - multicenter trial. Follow-up included standardized assessments of response, - serious ADRs and therapeutic drug monitoring. - , Results - 710 youth (age=14.6±2.2 years, - female=66.6%) were observed for 5.5 months on average; - 76.3% received antidepressants, 47.5% antipsychotics, and - 25.2% both. Altogether, 55.2% of the treatment episodes with - antidepressants and 80.7% with antipsychotics were off-label. Serious - ADRs occurred in 8.3% (95%CI=6.4-10.6%) - of patients, mainly being psychiatric adverse reactions (77.4%), - predominantly suicidal ideation and behavior. The risk of serious ADRs was not - significantly different between patients using psychotropics off-label and - on-label (antidepressants: 8.1% vs. 11.3%, p=0.16; - antipsychotics: 8.7% vs 7.5%, p=0.67). Serious ADRs - occurred in 16.6% of patients who were suicidal at enrollment versus - 5.6% of patients who were not suicidal (relative risk 3.0, - 95%CI=1.9-4.9). - , Conclusion - Off-label use of antidepressants and antipsychotics in youth - was not a risk factor for the occurrence of serious ADRs in a closely monitored - clinical setting. Results from large naturalistic trials like ours can - contribute to bridging the gap between knowledge from randomized controlled - trials and real-world clinical settings. | ||
| 700 | 1 | |a Gerlach, Manfred |d 1954- |e VerfasserIn |0 (DE-588)133091171 |0 (DE-627)534482716 |0 (DE-576)187975086 |4 aut | |
| 700 | 1 | |a Correll, Christoph U. |e VerfasserIn |0 (DE-588)141700556 |0 (DE-627)704045192 |0 (DE-576)325437122 |4 aut | |
| 700 | 1 | |a Plener, Paul L. |d 1978- |e VerfasserIn |0 (DE-588)143944347 |0 (DE-627)704651971 |0 (DE-576)339813091 |4 aut | |
| 700 | 1 | |a Malzahn, Uwe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heuschmann, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Unterecker, Stefan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Scherf-Clavel, Maike |d 19XX- |e VerfasserIn |0 (DE-588)1133023347 |0 (DE-627)888167784 |0 (DE-576)489054099 |4 aut | |
| 700 | 1 | |a Rock, Hans |e VerfasserIn |4 aut | |
| 700 | 1 | |a Antony, Gisela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Briegel, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |8 1\p |a Fleischhaker, Christian |e VerfasserIn |0 (DE-588)114863342 |0 (DE-627)621546917 |0 (DE-576)17733679X |4 aut | |
| 700 | 1 | |a Häge, Alexander |d 1979- |e VerfasserIn |0 (DE-588)136964397 |0 (DE-627)588725773 |0 (DE-576)30136561X |4 aut | |
| 700 | 1 | |a Hellenschmidt, Tobias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Imgart, Harmut |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kaess, Michael |d 1979- |e VerfasserIn |0 (DE-588)136367240 |0 (DE-627)694324248 |0 (DE-576)300984766 |4 aut | |
| 700 | 1 | |a Karwautz, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kölch, Michael |d 1970- |e VerfasserIn |0 (DE-588)13264195X |0 (DE-627)524714649 |0 (DE-576)187248575 |4 aut | |
| 700 | 1 | |a Reitzle, Karl |e VerfasserIn |4 aut | |
| 700 | 1 | |a Renner, Tobias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reuter-Dang, Su-Yin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rexroth, Christian A. |d 1972- |e VerfasserIn |0 (DE-588)122969979 |0 (DE-627)082267464 |0 (DE-576)293500460 |4 aut | |
| 700 | 1 | |a Schulte-Körne, Gerd |e VerfasserIn |4 aut | |
| 700 | 1 | |a Theisen, Frank M. |e VerfasserIn |4 aut | |
| 700 | 1 | |8 2\p |a Walitza, Susanne |d 1969- |e VerfasserIn |0 (DE-588)121146030 |0 (DE-627)081116144 |0 (DE-576)182389405 |4 aut | |
| 700 | 1 | |a Wewetzer, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fekete, Stefanie |d 19XX- |e VerfasserIn |0 (DE-588)1175409138 |0 (DE-627)104634112X |0 (DE-576)51617536X |4 aut | |
| 700 | 1 | |a Taurines, Regina |d 1977- |e VerfasserIn |0 (DE-588)130433217 |0 (DE-627)501471901 |0 (DE-576)29819306X |4 aut | |
| 700 | 1 | |a Romanos, Marcel |d 1975- |e VerfasserIn |0 (DE-588)128858583 |0 (DE-627)383661781 |0 (DE-576)297366769 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacopsychiatry |d Stuttgart [u.a.] : Thieme, 1984 |g 55(2022), 5, Seite 255-265 |h Online-Ressource |w (DE-627)326977503 |w (DE-600)2041961-2 |w (DE-576)26359355X |x 1439-0795 |7 nnas |a Serious adverse drug reactions in children and adolescents treated on- and off-label with antidepressants and antipsychotics in clinical practice |
| 773 | 1 | 8 | |g volume:55 |g year:2022 |g number:5 |g pages:255-265 |g extent:11 |a Serious adverse drug reactions in children and adolescents treated on- and off-label with antidepressants and antipsychotics in clinical practice |
| 856 | 4 | 0 | |u https://doi.org/10.1055/a-1716-1856 |x Resolving-System |z kostenfrei |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458344/ |x Verlag |z kostenfrei |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 2\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20230925 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 136367240 |a Kaess, Michael |m 136367240:Kaess, Michael |d 910000 |d 910600 |e 910000PK136367240 |e 910600PK136367240 |k 0/910000/ |k 1/910000/910600/ |p 16 | ||
| 998 | |g 136964397 |a Häge, Alexander |m 136964397:Häge, Alexander |d 60000 |e 60000PH136964397 |k 0/60000/ |p 13 | ||
| 999 | |a KXP-PPN1826462554 |e 4378804964 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","family":"Egberts","display":"Egberts, Karin M.","given":"Karin M."},{"role":"aut","given":"Manfred","display":"Gerlach, Manfred","family":"Gerlach"},{"role":"aut","given":"Christoph U.","display":"Correll, Christoph U.","family":"Correll"},{"family":"Plener","given":"Paul L.","display":"Plener, Paul L.","role":"aut"},{"family":"Malzahn","given":"Uwe","display":"Malzahn, Uwe","role":"aut"},{"given":"Peter","display":"Heuschmann, Peter","family":"Heuschmann","role":"aut"},{"family":"Unterecker","given":"Stefan","display":"Unterecker, Stefan","role":"aut"},{"role":"aut","given":"Maike","display":"Scherf-Clavel, Maike","family":"Scherf-Clavel"},{"family":"Rock","given":"Hans","display":"Rock, Hans","role":"aut"},{"role":"aut","family":"Antony","given":"Gisela","display":"Antony, Gisela"},{"role":"aut","family":"Briegel","given":"Wolfgang","display":"Briegel, Wolfgang"},{"role":"aut","given":"Christian","display":"Fleischhaker, Christian","family":"Fleischhaker"},{"given":"Alexander","display":"Häge, Alexander","family":"Häge","role":"aut"},{"role":"aut","family":"Hellenschmidt","display":"Hellenschmidt, Tobias","given":"Tobias"},{"family":"Imgart","display":"Imgart, Harmut","given":"Harmut","role":"aut"},{"family":"Kaess","given":"Michael","display":"Kaess, Michael","role":"aut"},{"role":"aut","family":"Karwautz","display":"Karwautz, Andreas","given":"Andreas"},{"given":"Michael","display":"Kölch, Michael","family":"Kölch","role":"aut"},{"role":"aut","family":"Reitzle","display":"Reitzle, Karl","given":"Karl"},{"given":"Tobias","display":"Renner, Tobias","family":"Renner","role":"aut"},{"role":"aut","display":"Reuter-Dang, Su-Yin","given":"Su-Yin","family":"Reuter-Dang"},{"role":"aut","display":"Rexroth, Christian A.","given":"Christian A.","family":"Rexroth"},{"display":"Schulte-Körne, Gerd","given":"Gerd","family":"Schulte-Körne","role":"aut"},{"role":"aut","given":"Frank M.","display":"Theisen, Frank M.","family":"Theisen"},{"given":"Susanne","display":"Walitza, Susanne","family":"Walitza","role":"aut"},{"family":"Wewetzer","given":"Christoph","display":"Wewetzer, Christoph","role":"aut"},{"family":"Fekete","display":"Fekete, Stefanie","given":"Stefanie","role":"aut"},{"given":"Regina","display":"Taurines, Regina","family":"Taurines","role":"aut"},{"role":"aut","display":"Romanos, Marcel","given":"Marcel","family":"Romanos"}],"recId":"1826462554","origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"1 September 2022"}],"name":{"displayForm":["authors: Karin M. Egberts, Manfred Gerlach, Christoph U. Correll, Paul L. Plener, Uwe Malzahn, Peter Heuschmann, Stefan Unterecker, Maike Scherf-Clavel, Hans Rock, Gisela Antony, Wolfgang Briegel, Christian Fleischhaker, Alexander Häge, Tobias Hellenschmidt, Harmut Imgart, Michael Kaess, Andreas Karwautz, Michael Kölch, Karl Reitzle, Tobias Renner, Su-Yin Reuter-Dang, Christian Rexroth, Gerd Schulte-Körne, Frank M. Theisen, Susanne Walitza, Christoph Wewetzer, Stefanie Fekete, Regina Taurines, Marcel Romanos"]},"language":["eng"],"title":[{"title":"Serious adverse drug reactions in children and adolescents treated on- and off-label with antidepressants and antipsychotics in clinical practice","title_sort":"Serious adverse drug reactions in children and adolescents treated on- and off-label with antidepressants and antipsychotics in clinical practice"}],"physDesc":[{"noteIll":"Illustrationen, Tabellen, Diagramme","extent":"11 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1055/a-1716-1856"],"eki":["1826462554"]},"relHost":[{"language":["eng"],"disp":"Serious adverse drug reactions in children and adolescents treated on- and off-label with antidepressants and antipsychotics in clinical practicePharmacopsychiatry","recId":"326977503","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["17.1984 -"],"title":[{"title":"Pharmacopsychiatry","subtitle":"clinical pharmacology, psychiatry, psychology, neurophysiology, neurobiology, gerontopsychiatry ; official organ of Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)","title_sort":"Pharmacopsychiatry"}],"origin":[{"dateIssuedDisp":"1984-","publisher":"Thieme","publisherPlace":"Stuttgart [u.a.]","dateIssuedKey":"1984"}],"note":["Gesehen am 05.07.22"],"part":{"issue":"5","extent":"11","pages":"255-265","year":"2022","volume":"55","text":"55(2022), 5, Seite 255-265"},"id":{"eki":["326977503"],"issn":["1439-0795"],"doi":["10.1055/s-00000054"],"zdb":["2041961-2"]},"physDesc":[{"extent":"Online-Ressource"}]}]} | ||
| SRT | |a EGBERTSKARSERIOUSADV1202 | ||